China SXT Pharmaceuticals (SXTC) Competitors $1.57 0.00 (0.00%) Closing price 08/22/2025 03:55 PM EasternExtended Trading$1.57 +0.00 (+0.25%) As of 08/22/2025 04:12 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock SXTC vs. BGM, TNGX, STOK, DNA, AMLX, SIGA, SANA, PROK, MRVI, and ABUSShould you be buying China SXT Pharmaceuticals stock or one of its competitors? The main competitors of China SXT Pharmaceuticals include BGM Group (BGM), Tango Therapeutics (TNGX), Stoke Therapeutics (STOK), Ginkgo Bioworks (DNA), Amylyx Pharmaceuticals (AMLX), Siga Technologies (SIGA), Sana Biotechnology (SANA), ProKidney (PROK), Maravai LifeSciences (MRVI), and Arbutus Biopharma (ABUS). These companies are all part of the "pharmaceutical products" industry. China SXT Pharmaceuticals vs. Its Competitors BGM Group Tango Therapeutics Stoke Therapeutics Ginkgo Bioworks Amylyx Pharmaceuticals Siga Technologies Sana Biotechnology ProKidney Maravai LifeSciences Arbutus Biopharma BGM Group (NASDAQ:BGM) and China SXT Pharmaceuticals (NASDAQ:SXTC) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, media sentiment, valuation, profitability, earnings, risk, institutional ownership and analyst recommendations. Does the media favor BGM or SXTC? In the previous week, China SXT Pharmaceuticals had 1 more articles in the media than BGM Group. MarketBeat recorded 1 mentions for China SXT Pharmaceuticals and 0 mentions for BGM Group. China SXT Pharmaceuticals' average media sentiment score of 1.95 beat BGM Group's score of 0.00 indicating that China SXT Pharmaceuticals is being referred to more favorably in the news media. Company Overall Sentiment BGM Group Neutral China SXT Pharmaceuticals Very Positive Is BGM or SXTC more profitable? Company Net Margins Return on Equity Return on Assets BGM GroupN/A N/A N/A China SXT Pharmaceuticals N/A N/A N/A Do institutionals and insiders hold more shares of BGM or SXTC? 5.0% of China SXT Pharmaceuticals shares are held by institutional investors. 58.7% of BGM Group shares are held by insiders. Comparatively, 4.0% of China SXT Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Which has preferable earnings & valuation, BGM or SXTC? BGM Group has higher revenue and earnings than China SXT Pharmaceuticals. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBGM Group$25.10M30.27-$1.44MN/AN/AChina SXT Pharmaceuticals$1.74M104.69-$3.30MN/AN/A Which has more risk and volatility, BGM or SXTC? BGM Group has a beta of 1.26, indicating that its share price is 26% more volatile than the S&P 500. Comparatively, China SXT Pharmaceuticals has a beta of 1.24, indicating that its share price is 24% more volatile than the S&P 500. SummaryBGM Group and China SXT Pharmaceuticals tied by winning 4 of the 8 factors compared between the two stocks. Get China SXT Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SXTC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SXTC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SXTC vs. The Competition Export to ExcelMetricChina SXT PharmaceuticalsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$182.16M$2.53B$5.81B$9.76BDividend YieldN/A1.67%4.39%4.06%P/E RatioN/A22.9031.3626.05Price / Sales104.69516.56387.8788.42Price / CashN/A179.1038.0259.36Price / Book0.075.939.536.60Net Income-$3.30M$31.83M$3.26B$265.65M7 Day Performance-2.48%1.89%2.14%2.00%1 Month Performance-3.09%1.62%3.22%0.46%1 Year Performance-76.91%9.25%30.18%18.88% China SXT Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SXTCChina SXT Pharmaceuticals0.7412 of 5 stars$1.57flatN/A-77.9%$182.16M$1.74M0.0090News CoveragePositive NewsShort Interest ↑Gap DownBGMBGM GroupN/A$7.62+0.1%N/A+39.6%$738.39M$25.10M0.00298TNGXTango Therapeutics1.6346 of 5 stars$6.61+3.1%$10.33+56.4%-40.4%$734.09M$42.07M-4.9690Insider TradeSTOKStoke Therapeutics4.5611 of 5 stars$13.23+0.5%$25.80+95.1%+39.8%$722.36M$36.56M16.75100DNAGinkgo Bioworks1.0612 of 5 stars$12.24+2.9%$8.50-30.6%+53.6%$711.67M$227.04M-2.07640AMLXAmylyx Pharmaceuticals3.4363 of 5 stars$7.90+1.0%$11.75+48.7%+317.0%$704.35M$87.37M-3.16200News CoverageSIGASiga Technologies2.0985 of 5 stars$9.47-0.2%N/A-3.8%$676.00M$138.72M8.3540News CoverageOptions VolumeSANASana Biotechnology2.9545 of 5 stars$2.98+2.1%$8.00+168.3%-38.7%$668.10MN/A-3.37380PROKProKidney3.7319 of 5 stars$2.28+0.7%$6.25+174.7%+0.8%$665.89M$80K-3.793News CoverageShort Interest ↓MRVIMaravai LifeSciences4.0252 of 5 stars$2.55+24.0%$6.64+159.9%-72.5%$651.93M$259.18M-2.25610Options VolumeGap UpABUSArbutus Biopharma2.734 of 5 stars$3.39+1.0%$5.50+62.5%-7.7%$646.99M$6.17M-11.6490News CoveragePositive News Related Companies and Tools Related Companies BGM Group Alternatives Tango Therapeutics Alternatives Stoke Therapeutics Alternatives Ginkgo Bioworks Alternatives Amylyx Pharmaceuticals Alternatives Siga Technologies Alternatives Sana Biotechnology Alternatives ProKidney Alternatives Maravai LifeSciences Alternatives Arbutus Biopharma Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SXTC) was last updated on 8/24/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding China SXT Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share China SXT Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access